[Treatment of Paget's disease of bone: importance of the zoledronic acid].

Abstract excerpt

Paget's disease is a localised monostotic or polyostotic bone disease of unknown origin. It may be caused by a slow viral infection and/or genetic factors. It is characterised by increased bone remodelling and an initially excessive osteoclastic bone resorption, followed by a secondary increase in osteoblastic activity, leading to replacement of the normal bone by a disorganized, enlarged, and weakened osseous...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Bone Density Conservation Agents
• Share to Bone Resorption
• Share to Calcitonin